Singapore Eclinical Solutions Market Size & Outlook
Singapore eclinical solutions market, 2018-2030 (US$M)
Related Markets
Singapore eclinical solutions market highlights
- The Singapore eclinical solutions market generated a revenue of USD 154.6 million in 2023 and is expected to reach USD 434.0 million by 2030.
- The Singapore market is expected to grow at a CAGR of 15.9% from 2024 to 2030.
- In terms of segment, ctms was the largest revenue generating product in 2023.
- ECOA is the most lucrative product segment registering the fastest growth during the forecast period.
Eclinical solutions market data book summary
| Market revenue in 2023 | USD 154.6 million |
| Market revenue in 2030 | USD 434.0 million |
| Growth rate | 15.9% (CAGR from 2023 to 2030) |
| Largest segment | Ctms |
| Fastest growing segment | ECOA |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | ECOA, EDC & CDMS, Clinical Analytics Platforms, Clinical Data Integration Platforms, Safety solutions, CTMS, RTSM, ETMF, EConsent |
| Key market players worldwide | DATATRAK International Inc, Oracle Corp, PAREXEL, Dassault Systemes SE, Signant Health, Clario, eClinicalWorks, International Business Machines Corp, IQVIA Holdings Inc, Veeva Systems Inc Class A, Anju Software, MaxisIT Inc., Castor |
Other key industry trends
- In terms of revenue, Singapore accounted for 1.1% of the global eclinical solutions market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan eclinical solutions market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,612.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
EClinical Solutions Market Scope
EClinical Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Singapore eclinical solutions market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to eclinical solutions market will help companies and investors design strategic landscapes.
Ctms was the largest segment with a revenue share of 20.5% in 2023. Horizon Databook has segmented the Singapore eclinical solutions market based on ecoa, edc & cdms, clinical analytics platforms, clinical data integration platforms, safety solutions, ctms, rtsm, etmf, econsent covering the revenue growth of each sub-segment from 2018 to 2030.
Singapore is presumed to witness steady growth rate over the coming years owing to the presence of healthcare organizations consistently striving to improve the clinical research and associated solutions. For instance, the Singapore Clinical Research Institute (SCRI) is a national academic research organization working in the direction to enhance human clinical research standards. It also encourages various medical devices, pharmaceutical, and biotechnological, as well as academic investigators to incorporate high-end solutions.
Reasons to subscribe to Singapore eclinical solutions market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Singapore eclinical solutions market databook
-
Our clientele includes a mix of eclinical solutions market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Singapore eclinical solutions market , including forecasts for subscribers. This country databook contains high-level insights into Singapore eclinical solutions market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Singapore eclinical solutions market size, by product, 2018-2030 (US$M)
Singapore EClinical Solutions Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
